IMP3: a new and important biomarker of systemic malignancies

Clinical Cancer Research

Volumn 14, Issue 17, 2008, Pages 5640-

  Kapoor, Shailendra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN IMP3; RNA BINDING PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; IMP 3 PROTEIN, HUMAN; IMP-3 PROTEIN, HUMAN; TUMOR PROTEIN;

BLADDER CARCINOMA; CANCER INVASION; CELL PROLIFERATION; DISEASE MARKER; ENDOMETRIUM CANCER; HUMAN; KIDNEY CARCINOMA; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA; NEOPLASM; NOTE;

HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROGNOSIS; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 53049101339     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0813     Document Type: Letter

References (9)

1. Sitnikova L, Mendese G, Liu Q, et al. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder. Clin Cancer Res 2008;14:1701-6.
2. Zheng W,Yi X, Fadare O, et al. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma. Am J Surg Pathol 2008;32:304-15.
3. Li C, Rock KL,Woda BA, Jiang Z, Fraire AE, Dresser K. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression. Mod Pathol 2007;20:242-7.
4. Yantiss RK, Woda BA, Fanger GR, et al. KOC(K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 2005; 29:188-95.
5. Jiang Z, Chu PG, Woda BA, et al. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol 2006;7:556-64.
6. Hoffmann NE, SheininY, Lohse CM, et al. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer 2008;112:1471-9.
7. Liao B, Hu Y, Herrick DJ, Brewer G. The RNA-binding protein IMP-3 is a transla-tional activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem 2005;280:18517-24.
8. Vikesaa J, Hansen TV, Jonson L, et al. RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J 2006;25:1456-68.
9. Suda T, Tsunoda T, Daigo Y, Nakamura Y, Tahara H. Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy. Cancer Sci 2007.